ACTRN12619001248156已完成未知
IMPROVE (Immunoglobulins in Myeloma Patients: Research into Outcomes, Variation in practice, and Epidemiology) – Improving immunoglobulin stewardship and clinical outcomes for patients with myeloma, using the Australian and New Zealand Myeloma and Related Diseases Registry.
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 328
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Newly diagnosed with multiple myeloma
- •A participant in the MRDR Registry
排除标准
- •Patients who decline to participate
- •Patients who do not have a diagnosis of multiple myeloma
研究者
相似试验
进行中（未招募）
不适用
Is a PET/MRI scan better than a PET/CT scan at visualising bone lesions and their change with treatment in adults with myeloma?CancerISRCTN15606951King's College London20
进行中（未招募）
1 期
Impact of lenalidomide on immune cell expression in multiple myelomaMedDRA version: 21.0Level: LLTClassification code 10028228Term: Multiple myelomaSystem Organ Class: 100000004864Multiple MyelomaEUCTR2021-000987-31-FRCHU Rennes22
已完成
1 期
Specific immunotherapy for multiple myeloma using vaccine complex consisting of idiotype protein and monosodium urate crystals (phase I study)multiple myelomaJPRN-UMIN000002290ational Hospital Organization Awara Hospital18
已完成
不适用
Assessing Free Immunoglobulin Light Chains in Patients With MyelomaMultiple MyelomaNCT00301275Royal Marsden NHS Foundation Trust
已完成
2 期
A Study to Desensitize Allergic Reactions to Treatments for Blood DisordersMultiple MyelomaAmyloidosisNCT03959358University Health Network, Toronto10